Cargando…

MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer

We examined microRNA-200c (miR-200c) expression in tumor tissues and plasma of patients with advanced gastric cancer and correlated miR-200c expression with treatment efficacy of platinum chemotherapy and patient prognosis. Tumor tissues were collected from 51 patients with advanced gastric cancer w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Min, Gu, Kangsheng, Liu, Wei, Xie, Xiaoque, Huang, Xiaolu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584241/ https://www.ncbi.nlm.nih.gov/pubmed/28881640 http://dx.doi.org/10.18632/oncotarget.17087

Ejemplares similares

MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway
por: Li, Min, et al.
Publicado: (2019)

Correlation between miR-138-5p expression and efficacy of platinum-based chemotherapy in advanced gastric cancer patients
por: Ning, Jie, et al.
Publicado: (2020)

MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein
por: Wei, Xiaoli, et al.
Publicado: (2019)

New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy
por: Koo, Dong-Hoe, et al.
Publicado: (2021)

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015)

Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Integrated characterization and validation of the prognostic significance of microRNA-200s in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2020)

MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis
por: Shi, Min, et al.
Publicado: (2018)

Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
por: Park, Ji Soo, et al.
Publicado: (2011)

MicroRNA-200c Nanoparticles Sensitized Gastric Cancer Cells to Radiotherapy by Regulating PD-L1 Expression and EMT
por: Qian, Lingyu, et al.
Publicado: (2020)

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
por: Bellmunt, Joaquim, et al.
Publicado: (2016)

Down-regulation of microRNA-200b is a potential prognostic marker of lung cancer in southern-central Chinese population
por: Li, Wen, et al.
Publicado: (2019)

Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer
por: Zang, Hongjing, et al.
Publicado: (2017)

Prognostic microRNAs associated with phosphoserine aminotransferase 1 in gastric cancer as markers of bone metastasis
por: Ma, Jingwei, et al.
Publicado: (2022)

Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
por: Reese, Moritz, et al.
Publicado: (2020)

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
por: Yu, Xiaotang, et al.
Publicado: (2020)

MicroRNA 200a as a histologically independent marker for meningioma recurrence: Results of a four microRNA panel analysis in meningiomas
por: Urbschat, Steffi, et al.
Publicado: (2022)

Prognostic value of microRNAs in gastric cancer: a meta-analysis
por: Zhang, Yue, et al.
Publicado: (2017)

Platinum-Based Versus Non-Platinum-Based Chemotherapy as First Line Treatment of Inoperable, Advanced Gastric Adenocarcinoma: A Meta-Analysis
por: Chen, Wei-Wei, et al.
Publicado: (2013)

The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma
por: Snowdon, Jaime, et al.
Publicado: (2011)

Emerging Role of MicroRNA-200 Family in Dentistry
por: Hsieh, Pei-Ling, et al.
Publicado: (2021)

Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma
por: Costa, Fabricio F., et al.
Publicado: (2011)

MicroRNAs as prognostic markers and therapeutic targets in gliomas
por: Sufianov, Albert, et al.
Publicado: (2022)

Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis
por: Zhang, Fei, et al.
Publicado: (2019)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
por: Della Pepa, Chiara, et al.
Publicado: (2014)

An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy
por: Liu, Gongyuan, et al.
Publicado: (2023)

ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
por: Palomba, Grazia, et al.
Publicado: (2014)

Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis
por: Wu, Jianchun, et al.
Publicado: (2015)

Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms
por: Li, Xiao-yang, et al.
Publicado: (2015)

Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis
por: Lee, Jung Soo, et al.
Publicado: (2017)

MicroRNA‐200 families and prognostic value in various carcinomas: A systematic review and meta‐analysis
por: Yin, Yuan, et al.
Publicado: (2018)

Prognostic Value of microRNA Signature in Patients with Gastric Cancers
por: Liu, Hai-Ting, et al.
Publicado: (2017)

MicroRNA-200c is involved in proliferation of gastric cancer by directly repressing p27(Kip1)
por: Wang, Yangyang, et al.
Publicado: (2016)

Expression Profiles of Circulating MicroRNAs in XELOX-Chemotherapy-Induced Peripheral Neuropathy in Patients with Advanced Gastric Cancer
por: Ju, Yeongdon, et al.
Publicado: (2022)

MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion
por: Zhang, Zhengliang, et al.
Publicado: (2015)

MicroRNA-466 and microRNA-200 increase endothelial permeability in hyperglycemia by targeting Claudin-5
por: Kujawa, Marisa, et al.
Publicado: (2022)

Regulation of microRNA-200c in cancer stem cells
por: Wu, Meng-Ju, et al.
Publicado: (2015)

The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition
por: Paterson, Emily L., et al.
Publicado: (2008)

MicroRNA 200a inhibits liver fibrosis of schistosoma
por: Xu, Ailei, et al.
Publicado: (2021)

Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer
por: Tanabe, Shihori, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_no3bb4dj4vg8tm3c0c4timb6v4